Eur Urol Oncol: Oncology outcome prediction for small kidney tumors

Currently, most patients diagnosed with kidney cancer present with small kidney masses (SRMs
).

Recently, researchers from the United States published an article in Eur Urol, in which researchers tried to improve prognostic models
that predict metastasis-free survival after nephrectomy by focusing on the clinicopathological features of SRMs associated with adverse outcomes.

The study included consecutive patients who
underwent surgical resection of SRMs (≤4 cm) in the University of Texas' Southwestern Kidney Cancer Project between 1998 and 2020.

A total of 3900 assessable nephrectomy procedures (from 3674 patients of different races) were included in the study, of which 1984 (51%) were SRMs, including 1720 RCs
.

The relationship between tumor size and metastasis-free survival and overall survival

In summary, the researchers identified clinicopathological features
that affect metastasis-free survival in SRMRCC patients.

Original Source:

Payal Kapur， Hua Zhong， Ellen Araj et al.